<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03045042</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-BIO-2017-02</org_study_id>
    <secondary_id>GZ-2015-11342</secondary_id>
    <nct_id>NCT03045042</nct_id>
  </id_info>
  <brief_title>Search for Serum/Plasma Biomarkers in Pompe's Disease</brief_title>
  <acronym>BIOPOMPE</acronym>
  <official_title>Search for Serum/Plasma Biomarkers in Pompe's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Genzyme, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to analyze serum and plasma samples from patients with late onset Pompe
      disease treated and not treated with enzyme replacement therapy (ERT) to identify microRNA
      that could be specific of the disease. The investigators will correlate the concentration of
      these microRNA with several muscle function tests and quantitative muscle MRI to know whether
      they are good biomarkers of progression.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MicroRNA in serum samples</measure>
    <time_frame>Baseline</time_frame>
    <description>Investigators are going to study microRNA following a microarray analysis of serum samples from patients treated and non treated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle function test</measure>
    <time_frame>Baseline and one year</time_frame>
    <description>6 minutes walking test (6MWT), time to climb 4 steps, time to descend 4 steps, Activlim, time to walk 10 meter, Medical Research Council scale (MRC), myometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Whole body muscle MRI</measure>
    <time_frame>Baseline a and one year</time_frame>
    <description>2 point dixon studies of thigh muscles</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in microRNA concentration</measure>
    <time_frame>One year period</time_frame>
    <description>Investigators will analyze concentration of microRNA after one year follow up in every single patients</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Late Onset Pompe Disease</condition>
  <condition>Pompe Disease</condition>
  <arm_group>
    <arm_group_label>Treated patients</arm_group_label>
    <description>Patients with late onset Pompe disease treated with the enzyme replacement therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non treated patients</arm_group_label>
    <description>Patients with late onset Pompe disease non treated with the enzyme replacement therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enzyme Replacement Agent</intervention_name>
    <description>Patients will be treated following the decision of their doctors. The investigators are going to analyze serum samples of these patients</description>
    <arm_group_label>Treated patients</arm_group_label>
    <other_name>Myozyme</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Late onset Pompe patiens
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Genetic confirmation of Pompe disease

        Exclusion Criteria:

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eduard Gallardo, PhD</last_name>
    <phone>9355657682</phone>
    <email>egallardo@santpau.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jordi Díaz Manera, MD PhD</last_name>
    <phone>935565986</phone>
    <email>jdiazm@santpau.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eduard Gallardo, PhD</last_name>
      <phone>+349355657692</phone>
      <email>egallardo@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jordi Díaz-Manera, Md PhD</last_name>
      <phone>+34935565986</phone>
      <email>jdiazm@santpau.cat</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>March 17, 2017</last_update_submitted>
  <last_update_submitted_qc>March 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pompe</keyword>
  <keyword>microRNA</keyword>
  <keyword>biomarker</keyword>
  <keyword>muscle MRI</keyword>
  <keyword>glycogenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycogen Storage Disease Type II</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

